Medical-device maker Medtronic is in advanced talks to combine with rival Covidien in a deal valued at more than $40 billion, according to people familiar with the matter.
Medtronic, Covidien in advanced talks to combine
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.